FROM THE NATIONAL CAMPAIGN TO PROTECT PEOPLE IN PAIN: A REUNDERSTANDING AND RESTORING SCIENTIFIC PRINCIPLES, INTEGRITY AND COMPASSION IN CHRONIC PAIN CARE

from youarewithinthenorms.com

NORMAN J CLEMENT RPH., DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC., SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT BS., MS, MBA. HARVEY JENKINS, MD, PH.D., IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., M.B.A., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., EVELYN J. CLEMENT, IN THE SPIRIT OF WALTER F. WRENN III., MD., JULIE KILLINGSWORTH, RENEE BLARE, RPH, DR. TERENCE SASAKI, MD LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, IN THE SPIRIT OF WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., IN THE SPIRIT OF RICHARD KAUL, MD., IN THE SPIRIT OF LEROY BAYLOR, JAY K. JOSHI MD., MBA, AISHA GARDNER, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS

The impact of pain policy

Restoring Scientific Integrity and Compassion in Chronic Pain Care

INTRODUCTION

This presentation from youarewithinthenorms.com highlights the National Campaign to Protect People in Pain (NCP3) and its mission to restore scientific integrity to chronic pain management. We further have specifically spotlighted the case of Dr.Barbara D. Marino, MD, an MD Anderson Train Ob-Gyn Oncology Surgeon, facing significant prison time, as an example of what we describe as a “witch hunt” against clinicians.

This text addresses the question, “Is prevailing public policy on pain management employing opioid analgesics firmly grounded in science?”

Written from the perspective of advocates, such as Kayvan Haddadan, MD, a physical medicine & rehabilitation physician in Roseville, CA; Richard “Red” Lawhern, PhD; Glinda Dames-Fincher, sickle-cell anemia pain care; and Sara Lewis, RN, the federal overreach and legal fear have led healthcare providers to abandon legitimate patients, resulting in inhumane suffering and reliance on alternatives.

Available medical literature and clinical experience do not support the thesis that clinicians who prescribe in a continuing relationship with pain patients have measurably contributed to the widely discussed US “opioid crisis.”

To address these issues, the NCP3 coalition promotes the adoption of evidence-based clinical guidelines that distinguish legitimate medical care from the illicit drug crisis. By providing educational resources and challenging restrictive federal mandates, the organization seeks to protect the patient-provider relationship and ensure access to individualized treatment. 

The authors briefly summarize key findings from reviews of pertinent medical literature on pain treatment and the diagnosis of substance use disorder.

Medical doctors are widely understood to be inadequately trained in the diagnosis of both pain and addiction among their patients. In the contemporary healthcare landscape, a critical friction point has emerged between federal prescribing mandates and the objective requirements of clinical governance.

Healthcare administrators and clinical leads currently operate within a high-stakes environment where political pressure to curtail opioid prescribing often contradicts the medical necessity of individualized patient care. 

There is currently no consensus standard of practice to guide clinicians in either the prescription of opioids or the diagnosis of “substance use disorder” among patients treated for pain.

The National Campaign to Protect People in Pain (NCP3) aims to eliminate the stigma and systemic neglect faced by those in agony, ensuring that individualized, compassionate treatment remains a protected medical necessity.

statement

The National Campaign to Protect People in Pain (NCP3) is a strategic corrective to this trend. It brings together elite clinicians, researchers, and advocates to remove political interference from the delivery of evidence-based medicine. By synthesizing high-level clinical evidence and challenging the claim that this is the “Greatest Healthcare Fraud in US History,” the NCP3 provides the framework to restore safe, effective, and compassionate pain care. 

DISCUSSION OF MEDICAL FACTS

THE MEDICAL CRIME OF THOSE SUFFERING FROM SICKLE CELL DISEASE

“..HANDS UP DON’T SHOOT..”

Glinda Dames-Fincher, sickle-cell anemia patient and pain care advoccate has articulated;

“There are many of us Sickle Cell Disease patients who have dealt with severe stigma from doctors & nurses due to need for opioid pain medication for horrifically painful Sickle Cell pain crisis, especially if we live to adulthood.

This has been the case for us for over half a century, way before there was a so-called “opioid epidemic.” I had a friend who’s a nurse who took her adult son to the ER at the hospital she worked at due to a serious Sickle Cell pain crisis. He was denied treatment by an ER doctor who said to him & his mother that Sickle Cell patients were just drug seekers, and he wouldn’t give him any treatment & then walked out of the room.

He died the next day at another hospital due to multiple organ failure due to Sickle Cell complications. I’m sad to say this is not uncommon treatment for Sickle Cell Disease patients.

As an affected advocate myself, I feel there needs to be more direct communication with the Sickle Cell support & advocacy organizations about the National Campaign to Protect People in Pain.

Thanks, Dr. Norm, for what you do.“

NCP3 restoring the understanding of pain care

Sara Lewis, RN

“At some point, we have to ask:

Is this truly about patient safety—or has it become something else entirely? 

Because from where many of us are standing, it feels less like protection… and more like a system that is failing the very people it’s supposed to help. And when providers who genuinely care for chronic pain patients are labeled as criminals or “pill mills,” it starts to look less like oversight—and more like a witch hunt.

People need to wake up. 25% of ppl in the USA are in chronic pain, it’s an epidemic, and it’s one that if it doesn’t affect you directly, it will affect a loved one in your lifetime when they are in agony and given nothing. 

We must do better overall for humanity

Needs of Returning Citizens with Substance Use Disorders

This module covers the various health and social needs of previously incarcerated individuals with substance use disorders upon returning home to their Washington, D.C. communities. It discusses the resources available to returning citizens, the challenges they may face, and strategies providers can use to reduce them. The module also reviews policy recommendations to better support an individual’s transition from incarceration to reintegration into the community.

Comprehensive, Evidence-Based, Consensus Guidelines for Prescription of Opioids for Chronic Non-Cancer Pain from the American Society of Interventional Pain Physicians (ASIPP)

This course is jointly provided by the Postgraduate Institute for Medicine, HealthHIV, and the District of Columbia Department of Behavioral Health.

This webinar offers a focused overview of the 2023 Clinical Practice Guidelines from the American Society of Interventional Pain Physicians (ASIPP), highlighting evidence-based strategies for prescribing opioids to manage chronic non-cancer pain.

Led by Dr. Richard A. Lawhern, it addresses current challenges in pain management, emphasizes patient safety, and provides guidance on balancing effective treatment with regulatory compliance. This training is essential for healthcare professionals navigating the evolving landscape of opioid prescribing while ensuring patients maintain access to appropriate, individualized care.

Educational Objectives

Apply guideline-informed approaches to balance effective pain management using multiple modalities while preserving patient access to appropriate therapies.

Describe recommendations in the updated 2023 Practice Guidelines of the American Society for Interventional Pain Physicians (ASIPP) for the prescription of opioids for chronic non-cancer pain.

National Campaign to Protect People in Pain (NCP3)

The primary goals of the National Campaign to Protect People in Pain (NCP3) center on restoring scientific integrity to pain management and ensuring patients have access to necessary care. Their core objectives include:

• Removing Political Interference: The central mission is to remove political interference from the delivery of evidence-based medicine. The campaign argues that current pain policies are often driven by political pressure rather than sound clinical literature.
• Restoring Compassionate Care: They are dedicated to restoring safe, effective, and compassionate pain care for people across America. This includes advocating for patient-centered treatment approaches that focus on the individual’s needs.
• Challenging Restrictive Guidelines: A major goal is to challenge the CDC and VA guidelines, which NCP3 claims are grounded in “fraudulent data and flawed science”. They seek to replace these restrictive policies with alternative standards, such as the ASIPP 2023 Consensus Guidelines on Opioids.
• Correcting Misinformation about the “Opioid Epidemic”: The campaign works to demonstrate that accidental overdose deaths are overwhelmingly driven by illicit street drugs rather than legal prescriptions provided by doctors to their patients.
• Ending Stigma and Discrimination: NCP3 aims to end the stigma and discrimination that people in pain frequently face in the healthcare system and broader society.
• Professional Education and Advocacy: They provide free, accredited Continuing Medical Education (CME) for clinicians and Continuing Legal Education (CLE) for attorneys to educate them on errors in current guidelines and how to defend the legitimacy of pain medicine.
• Influencing State Policy: Through a “lobbying playbook” and state board engagement, they work to drive changes in state medical and pharmacy board policies regarding opioid prescribing.

 Redefining the Epidemic: Illicit Street Drugs vs. Prescribed Medication

NCP3 research, supported by experts including Dr. William R. Bauer—who set in motion landmark pain legislation in Ohio—and Dr. Forest Tennant, a pioneer in arachnoiditis research and a partner in the NCP3-DocToks alliance, highlights the catastrophic consequences of conflating these issues. When regulatory pressure forces the abandonment of evidence-based prescribing, the healthcare system effectively abdicates its responsibility to the patient.

Ultimately, the NCP3 functions as a coalition of experts—including physicians, researchers, and patient advocates—working together to challenge what they describe as the “misdirection of US pain policy”. Dr. Kayvan Haddadan, MD, is a physical medicine & rehabilitation physician in Roseville, CA, with over 25 years of medical experience.

This course is jointly provided by the Postgraduate Institute for Medicine, HealthHIV, and the District of Columbia Department of Behavioral Health.

He graduated from Shahid Beheshti University of Medical Sciences, Faculty of Medicine in 1995. He is affiliated with medical facilities such as Adventist Health, Rideout, and Marshall Medical Center. He is accepting new patients and telehealth appointments.

summary conclusion

To reclaim scientific integrity and establish a legally defensible clinical standard, healthcare institutions must adopt the ASIPP 2023 Consensus Guidelines on Opioids. This framework offers a robust, evidence-based alternative to restrictive federal mandates, providing a pathway for clinicians to deliver care that is both safe and effective.

🔓 🔓 🔓 

ALL WATCHED OVER BY MACHINES OF LOVING GRACE

BE SURE TO DONATE TO THE MARK IBSEN GOFUNDME DEFENSE FUND, WHERE THE SON ALWAYS RISES!!!

OUR TREE OF KNOWLEDGE SHALL NEVER BE SUPPRESSED

FOR NOW, YOU ARE WITHIN

THE NORMS

REFERENCES